BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 286085)

  • 21. Cytotoxicity of lymphocytes and antibodies against autologous tumor cells in patients with myeloid leukaemias and preleukaemic disorders. III. Stage-dependence of oncovirus-specific immune response.
    Szabó B; Tóth FD; Váczi L; Kiss J; Réthy A; Kiss A; Rák K
    Acta Microbiol Hung; 1986; 33(2):103-10. PubMed ID: 3492851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quadriplegia and cranial nerve palsy during treatment by vincristine in blastic crisis of chronic myelocytic leukemia: report of an autopsy case].
    Fujishita M; Tamura A; Yamada M; Uemura Y; Niiya K; Yoshimoto S; Kubonishi I; Taguchi H; Yoshino T; Ohtsuki Y
    Rinsho Ketsueki; 1986 Aug; 27(8):1437-42. PubMed ID: 3467102
    [No Abstract]   [Full Text] [Related]  

  • 23. [A case of eosinophilic-basophilic meningitis developed during the course of chronic myelocytic leukemia in blastic crisis].
    Mimura K; Otsuka T; Niho Y; Yamada A; Nagasawa K; Okamura S
    Rinsho Ketsueki; 1984 Jan; 25(1):63-8. PubMed ID: 6589416
    [No Abstract]   [Full Text] [Related]  

  • 24. [Karyotype in chronic myeloid leukemia in a blastic crisis. I. Monosomy 16].
    Palka G; Geraci L; Caramelli E; Marino M; Felaco M; Laraia A; Antonucci A
    Boll Soc Ital Biol Sper; 1981 Jan; 57(2):145-8. PubMed ID: 6940605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of chronic myelocytic leukemia treated with splenectomy in the early stage of the blastic crisis (author's transl)].
    Endo K; Saeki S; Sato I; Suzuki T; Tajima G; Horino Y; Mikami M; Onodera S; Yoshinaga K
    Rinsho Ketsueki; 1979 Mar; 20(3):273-9. PubMed ID: 286083
    [No Abstract]   [Full Text] [Related]  

  • 26. Differentiation ability of peripheral blood cells from patients with acute leukemia or blast crisis in chronic myelocytic leukemia.
    Hoelzer D; Harriss EB; Kurrle E; Schmücker H; Hellriegel KP
    Haematol Blood Transfus; 1979; 23():217-21. PubMed ID: 296109
    [No Abstract]   [Full Text] [Related]  

  • 27. [Karyotype in chronic myeloid leukemia in a blastic crisis. II. Trisomy 17].
    Geraci L; Palka G; Felaco M; Miscia S; D'Antuono A; Caramelli E
    Boll Soc Ital Biol Sper; 1981 Jan; 57(2):149-51. PubMed ID: 6940606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of surface nonspecific cross-reacting antigen and influence of proteolytic enzymes on this antigen in myeloid cell series.
    Noworolska A; Harłozińska-Szmyrka A; Richter R
    Cancer Detect Prev; 1986; 9(3-4):365-71. PubMed ID: 3527416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cellular lymphoid involvement in the blastic metamorphosis of various chronic myeloid leukemias].
    Sánchez Fayos J; Outeiriño J
    Sangre (Barc); 1977; 22(6):994-1000. PubMed ID: 272066
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of myelocytic leukemia during blast transformation (preliminary report)].
    Frinovskaia IV; Bogomolova LV
    Sov Med; 1976 Aug; (8):28-32. PubMed ID: 1070163
    [No Abstract]   [Full Text] [Related]  

  • 31. [Acute clinical crisis and malignant cytology in chronic myeloid leukemia. Hematological considerations on the significance of "blastic crisis" in 25 cases].
    Sanchez-Fayos J; Outeiriño J; Paniagua G; Calabuig MT; Martinez Frejo MC
    Sangre (Barc); 1970; 15(2):209-25. PubMed ID: 5271128
    [No Abstract]   [Full Text] [Related]  

  • 32. [Acute clinical crisis and malignant cytology in chronic myeloid leukemia. Hematological considerations on the significance of "blastic crisis" in 25 cases].
    Sanchez-Fayos J; Outeiriño J; Paniagua G; Calabuig T; Martinez Frejo C
    Sangre (Barc); 1970; 15(2):209-25. PubMed ID: 5270389
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of chronic myelogenous leukemia and blastic crisis.
    Hellriegel KP
    Recent Results Cancer Res; 1984; 93():259-68. PubMed ID: 6382483
    [No Abstract]   [Full Text] [Related]  

  • 34. P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia.
    Carulli G; Petrini M; Marini A; Vaglini F; Caracciolo F; Grassi B
    Haematologica; 1990; 75(6):516-21. PubMed ID: 1982999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytogenetic study of cell sub-populations in human leukemias (AML, CML) sorted by flow cytometry].
    Lacombe F; Belloc F; Bernard P; Dachary D; Boisseau MR
    Pathol Biol (Paris); 1988 Jan; 36(1):42-5. PubMed ID: 3283670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphoblastic crisis in chronic myeloid leukemia.
    Singh NK; Singh DS; Srivastava PK; Dube RK; Bamezai R
    J Assoc Physicians India; 1983 Jun; 31(6):377-8. PubMed ID: 6581154
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mechanism of the development of extensive leukemic infiltration in the brain].
    Nowacki P
    Neuropatol Pol; 1987; 25(2):219-25. PubMed ID: 3481844
    [No Abstract]   [Full Text] [Related]  

  • 38. [The karyotype in the blastic crisis of chronic myeloid leukemia].
    Alimena G; Gastaldi R; De Cuia MR; Lombardi A; Dallapiccola B
    Recenti Prog Med; 1981 Mar; 70(3):259-70. PubMed ID: 7017849
    [No Abstract]   [Full Text] [Related]  

  • 39. [Origin and localization of leukemic cells in the central nervous system of adults with non-lymphoblastic leukemia].
    Nowacki P
    Neuropatol Pol; 1987; 25(1):7-19. PubMed ID: 3477707
    [No Abstract]   [Full Text] [Related]  

  • 40. Granulocytic sarcoma of testis preceding acute myelocytic leukemia.
    Kawashima H; Sakamoto W; Nishijima T; Hanada M; Mori K; Maekawa M
    Urol Int; 1988; 43(5):310-2. PubMed ID: 3201647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.